{"id":"54e8fc80-989d-5995-9183-ed58a6c89c34","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-fungal-metabolite-inhibits-lsd1","predicate":"produces","statement":"One of the dihydrocapsaicin metabolites obtained from intestinal fungal biotransformation showed significant inhibitory effect on lysine-specific demethylase 1 with a half-maximal inhibitory concentration of 1.99 micromolar.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"9811cb21-e440-53f2-965d-2b9e2194a3e4","mechanism_event_label":"One of those fungal products blocks an enzyme that edits chromatin, at a low concentration.","subject":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"object":{"id":"05375599-0d5f-5fca-8df5-1c38a3012788","slug":"kdm1a","display_name":"KDM1A","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"9811cb21-e440-53f2-965d-2b9e2194a3e4","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-fungal-metabolite-inhibits-lsd1-event","event_type":"biochemical_relationship","label":"One of those fungal products blocks an enzyme that edits chromatin, at a low concentration.","description":"One of the dihydrocapsaicin metabolites obtained from intestinal fungal biotransformation showed significant inhibitory effect on lysine-specific demethylase 1 with a half-maximal inhibitory concentration of 1.99 micromolar.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"401e173a-f8ce-5149-af74-37ef709a4548","slug":"intestinal-fungi","display_name":"Cultivated human intestinal fungal strains","entity_type_key":"cell_type"},"role":"producing_organism","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"05375599-0d5f-5fca-8df5-1c38a3012788","slug":"kdm1a","display_name":"KDM1A","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dihydrocapsaicin-research/36578383.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a36fc63af6f17ba1a551c87f5c73e288e9f468affcd39bcba5baad1ee1acf338\", \"start_char\": 0, \"end_char\": 1090, \"text_sha256\": \"a36fc63af6f17ba1a551c87f5c73e288e9f468affcd39bcba5baad1ee1acf338\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Biotransformation of dihydrocapsaicin by four cultivated human intestinal fungal strains with NMR and HRESIMS structure determination","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Dihydrocapsaicin incubated with cultivated human intestinal fungal strains","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"An in vitro biotransformation study with cultivated strains, not a gut community. The enzyme-inhibition result is a property of an isolated metabolite, not a demonstrated effect in an animal.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human intestinal fungi","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"One of those fungal products blocks an enzyme that edits chromatin, at a low concentration.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dhc-p36578383] Biotransformation of dihydrocapsaicin by human intestinal fungi and the inhibitory effects of metabolites against LSD1. (2022). https://pubmed.ncbi.nlm.nih.gov/36578383/ DOI: 10.1016/j.heliyon.2022.e12325","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"In vitro culture","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"494ad719-a7e5-5d08-8b1a-40d432ef520a","evidence_kind":"source_excerpt","locator":"Lines 582-593","start_line":582,"end_line":593,"excerpt":"### dhc-fungal-metabolite-inhibits-lsd1\nOne of the dihydrocapsaicin metabolites obtained from intestinal fungal biotransformation showed significant inhibitory effect on lysine-specific demethylase 1 with a half-maximal inhibitory concentration of 1.99 micromolar.\nCondition category: normal\nnutrient_topic: Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.\nplain_language: One of those fungal products blocks an enzyme that edits chromatin, at a low concentration.\norganism: Human intestinal fungi\ntissue_or_cell_type: In vitro culture\nexperimental_model: Biotransformation of dihydrocapsaicin by four cultivated human intestinal fungal strains with NMR and HRESIMS structure determination\nlimitations: An in vitro biotransformation study with cultivated strains, not a gut community. The enzyme-inhibition result is a property of an isolated metabolite, not a demonstrated effect in an animal.\nexposure: Dihydrocapsaicin incubated with cultivated human intestinal fungal strains\nevidence_span: {\"source_cache\": \"artifacts/dihydrocapsaicin-research/36578383.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a36fc63af6f17ba1a551c87f5c73e288e9f468affcd39bcba5baad1ee1acf338\", \"start_char\": 0, \"end_char\": 1090, \"text_sha256\": \"a36fc63af6f17ba1a551c87f5c73e288e9f468affcd39bcba5baad1ee1acf338\"}\n[dhc-p36578383] Biotransformation of dihydrocapsaicin by human intestinal fungi and the inhibitory effects of metabolites against LSD1. (2022). https://pubmed.ncbi.nlm.nih.gov/36578383/ DOI: 10.1016/j.heliyon.2022.e12325","model_system":"Biotransformation of dihydrocapsaicin by four cultivated human intestinal fungal strains with NMR and HRESIMS structure determination","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dhc-p36578383] Biotransformation of dihydrocapsaicin by human intestinal fungi and the inhibitory effects of metabolites against LSD1. (2022). https://pubmed.ncbi.nlm.nih.gov/36578383/ DOI: 10.1016/j.heliyon.2022.e12325","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"263a8425-969d-5a1b-8a9b-6101ba6a26a7","stable_key":"import-c953cca8-774f-596d-b27a-f13c2c0b5fce","title":"Dihydrocapsaicin: the second capsaicinoid, the hypothermia it is used to induce, what the gut and liver do to it, and what it does without TRPV1 (2026-09-21)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"97d90ff5dc65dc321068c3e2a0525585f32b2e17eb0c6bfa0d9ef26dc2d6c5a3","revision_id":"dbdc1ad7-a05a-579d-b2aa-c4348e3efc40","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}